Tag: Leviticus Cardio

Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease

Calon Cardio-Technology Ltd. and Leviticus-Cardio Ltd. announce the joint Development and Testing of a Wireless, Fully Implantable, Long-Term Blood Pump. SWANSEA, Wales and TEL AVIV, Israel, Jan. 10, 2022 /PRNewswire/ — Severe heart failure is the most life-threatening medical condition in all age groups across the globe. Implantable heart pumps, known as Ventricular Assist Devices (or VADs), have proven […]

Leviticus Cardio Appoints Prof. Nir Uriel to its Scientific Advisory Board

PETAH-TIKVA, Israel, Aug. 1, 2019 /PRNewswire/ — Leviticus Cardio today announced the appointment of Prof. Nir Urielto its Scientific Advisory Board. “We are very excited that Prof. Uriel has joined our Scientific Advisory Board. He is a leader in the field of heart failure, mechanical circulatory support and heart transplantation, and he will help us greatly in promoting our wireless solution to the LVAD […]

Leviticus Cardio Appoints Prof. Mandeep R. Mehra to Its Scientific Advisory Board

PETAH-TIKVA, Israel, July 16, 2019 /PRNewswire/ — Leviticus Cardio today announced the appointment of Prof. Mandeep R. Mehra to its Scientific Advisory Board. “We are very excited that Prof. Mehra has joined our Scientific Advisory Board. He is recognized as one of the world’s leading cardiologists in advanced heart failure and cardiac transplantation, and he will provide immediate benefits to our Company,” said […]

Leviticus Cardio Announces Success of Groundbreaking Six Month Chronic Animal Study

PETAH TIKVA, Israel, Dec. 6, 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system used with implanted left ventricular assist devices (LVADs), announces the successful completion of a 180-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump. Leviticus’ CET technology compliments a LVAD made by Jarvik […]

Leviticus Cardio Announces Successful Completion of Third Chronic Animal Study

PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump. The trial was conducted at a […]

Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study

PETAH TIKVA, Israel, April 10, 2018 /PRNewswire/ — Leviticus Cardio, the inventor of wireless power transfer for Left Ventricular Assisted Devices, or “LVADs”, for patients with severe cardiac issues, has announced another round of successful animal trials, well beyond periods required to demonstrate suitability for chronic conditions. The company confirms that the successful studies put it in a strong […]